Immunoassays – News and Features

Researchers discovered a new class of iron-targeting compounds that hamper the proliferation of cultured malignant cells in a laboratory setting. The new molecules exploit the iron dependency of malignant cells.

Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.

Innovative preclinical research in mice models has shown that a molecular imaging technique can reveal the presence of a protein called PD-L1 in glioblastomas – the most common type of cancerous brain tumour in adults.

Researchers reversed hearing loss in mice by restoring the function of a defective gene. The proof-of-concept study suggests that some types of hearing loss caused by reduced gene activity could be reversible.

Early diagnosis is likely to be essential in treating Alzheimer's disease. A team has demonstrated that tau PET - a novel imaging technique for visualizing the tau protein - can predict cognitive decline in patients much better than the imaging techniques normally used.

New study suggests harmful algal bloom toxicity varies over the summer.

A new nanoporous membrane allows highly efficient separation of wastewater components for reuse, offering industries sustainability and added-value benefits.

Based on decades of work to uncover the underlying mechanisms of asthma and other respiratory conditions, researchers have produced a simple, rapid test that can identify the presence of a key driver of severe asthma.

According to research, a green tea compound called epigallocatechin gallate could be promising for both preventing and treating uterine fibroids.

Revvity announced its newly established Scientific Centre of Excellence in Cambridge, where scientists can outsource their research needs to Revvity experts. Technology Networks visited the site to learn more about how Revvity is supporting its customers in their drug discovery efforts.